Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Gunnarsson, Martin; Malmeström, Clas; Axelsson, Markus; Sundström, Peter; Dahle, Charlotte; Vrethem, Magnus; Olsson, Tomas; Piehl, Fredrik; Norgren, Niklas; Rosengren, Lars; Svenningsson, Anders; Lycke, Jan

doi:10.1002/ana.22247

Public

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

Shared by NobleBlocks on Dec 8, 2010 • 12:00 AM UTC

Authors:

Martin Gunnarsson

Clas Malmeström

Markus Axelsson

Abstract

Abstract Objective: The impact of present disease‐modifying treatments (DMTs) in multiple sclerosis (MS) on nerve injury and reactive astrogliosis is still unclear. Therefore, we studied the effect of natalizumab treatment on the release of 2 brain‐specific tissue damage markers into cerebrospinal f...

Discussions